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Abstract 
We still do not understand why some individuals are more likely to develop OCD than others. 
Research has implicated the serotonin system specifically the serotonin transporter and the 5-
HT2A receptor as potential neurochemical underpinnings of OCD. Innovations in genetics have 
allowed research to hone in on the specific genes which code for the neurochemical dysfunction 
implicated in OCD. In this literature review, I gathered data in the form of research which 
addresses the neurochemical and genetic underpinnings of OCD in order to gain a better 
understanding of the etiology of the disorder. The findings presented represent my analysis of 
current research in the field in the hopes of drawing conclusions about the etiology of OCD. My 
conclusions implicate the specific genes which code for the serotonin transporter and the 5-HT2A 
receptor as the potential neurochemical and genetic underpinnings of OCD. 
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Chapter One 
Introduction 
Obsessive-compulsive disorder (OCD), a psychological disorder characterized by 
intrusive thoughts and out-of-control repetitive behaviors, is the fourth most common mental 
disorder, and yet to many the disorder remains a mystery. Individuals who develop the disorder 
are often unaware of its existence before they seek treatment and are diagnosed. These people 
suffer silently from invasive thoughts which cripple their ability to function normally, and yet 
most ironically of all, most are aware that their thought patterns and behaviors are irrational but 
still cannot control them. 
 James Bailey is an example of a case of OCD. In his memoir, Man, Interrupted, Bailey 
recounts his time at a treatment facility in Berkeley, California where he underwent exposure 
therapy for his OCD. Bailey’s obsessions revolved around drugs and drug users and the fear that 
they might contaminate him with mind-altering substances. Whenever Bailey came into contact 
with drugs or drug users, he was compelled to extricate himself from the situation to wash his 
hands in order to get rid of the contamination. Bailey understood that his obsessions and their 
corresponding compulsions were a product of his own mind, yet he still could not prevent 
himself from complying with their demands. Bailey’s case may seem peculiar, but for 
individuals with OCD, the thoughts and behaviors he exhibits are all too familiar (Bailey, 2006). 
 James Bailey is one example out of many documented cases of OCD. Why did Bailey 
and individuals like him develop this disorder when the rest of us did not? Could his genetics be 
responsible for the onset of his OCD? Maybe an imbalance of the chemicals in his brain known 
as neurotransmitters is to blame? These are two of the leading biological explanations in the field 
of research into the etiology of OCD and as such are the areas of research I will address in this 
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paper. Thus, the research question guiding my current paper is what are the neurochemical and 
genetic explanations for the etiology of OCD? 
What is OCD? 
OCD is an anxiety disorder characterized by obsessions or compulsions, with patients 
often exhibiting symptoms of both. The obsessions and compulsions are often connected in some 
way that makes sense to the patient but not necessarily to others. For example, a patient could 
have an obsession about harming his mother and the only way to reduce the anxiety brought on 
by this obsession is to compulsively count the cracks in the sidewalk (“step on a crack, break 
your mother’s back”). 
 In order to be diagnosed with OCD, patients must endorse criteria related to obsessions 
and compulsions. Obsessions are defined as “recurrent and persistent thoughts, impulses, or 
images” that are experienced as distressing “at some time during the disturbance” (American 
Psychiatric Association, 2000, p.462). These thoughts, images, or impulses cannot be “excessive 
worries about real-life problems” (American Psychiatric Association, 2000, p.462). The patient 
must attempt to cancel out the thoughts, impulses, or images “with some other thought or action” 
(American Psychiatric Association, 2000, p.462). Finally the patient must recognize “that the 
obsessional thoughts, impulses, or images are a product of his or her own mind” (American 
Psychiatric Association, 2000, p.462). 
 Compulsions are defined by “repetitive behaviors or mental acts that the person feels 
driven to perform in response to an obsession, or according to rules that must be applied rigidly” 
(American Psychiatric Association, 2000, p.462). In addition “the behaviors or mental acts are 
aimed at preventing or reducing distress or preventing some dreaded event or situation; however, 
these behaviors or mental acts either are not connected in a realistic way with what they are 
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designed to neutralize or prevent or are clearly excessive” (American Psychiatric Association, 
2000, p.462). 
 Obsessions or compulsions are the primary criterion for OCD; however, a patient must 
also endorse four more criteria to warrant a diagnosis. (1) The patient must recognize “at some 
point during the course of the disorder” that their behaviors or mental acts are “excessive or 
unreasonable” (American Psychiatric Association, 2000, p.462). (2) The patient’s obsessions or 
compulsions must “cause marked distress, (be) time consuming (e.g., take more than 1 hour a 
day), or significantly interfere with the person’s normal routine, occupational (or academic) 
functioning, or usual social activities or relationships” (American Psychiatric Association, 2000, 
p.463). (3) The obsessions or compulsions cannot be better explained by another axis I disorder, 
and “the disturbance (cannot be) due to the direct physiological effects of a substance or a 
general medical condition” (American Psychiatric Association, 2000, p.463). Finally, (4) the 
diagnostician must specify if the patient has poor insight into their condition meaning that the 
patient “does not recognize that the obsessions and compulsions are excessive or unreasonable” 
(APA, 2000, p.463). 
Psychosocial predictors 
 The onset of OCD is usually gradual and patients do not typically have an explanation for 
the development of their symptoms. However, there is at least one demonstrated psychosocial 
predictor of OCD: a traumatic life event. Several studies (de Silva & Marks, 1999; Gershuny et 
al., 2003; Pitman, 1993) have revealed an etiologic link between the presence of a traumatic life 
event and the onset of OCD.  Pitman (1993) found this link in the onset of OCD among combat 
veterans who had been exposed to trauma. De Silva & Marks (1999) identified this connection 
through a series of case studies of patients who had experienced trauma and developed OCD. 
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Gershuny and colleagues (2003) looked at the relationship between trauma and OCD through a 
series of four cases of individuals who met criteria for comorbid OCD and PTSD and examined 
connections between symptoms of OCD and PTSD. Cromer and colleagues’ (Cromer, Schmidt, 
& Murphy, 2007) study investigates the effect of traumatic life events on the severity and 
symptoms of a group of individuals diagnosed with OCD.  
Environmental predictors 
 In addition to the presence of a traumatic life event, environmental factors may play a 
role in predicting the onset of OCD. Classical conditioning is the psychological principle most 
often cited in the development of OCD. In the case of OCD, classical conditioning posits that 
when a particular stimulus is paired with anxiety or fear, an obsession is born. Foa & Kozak 
(1986) propose that emotions such as fear can be viewed as information structures in the memory 
of an individual. When an information structure is developed which ties fear to a particular 
obsessive stimulus, the individual develops OCD. For example, in the case of James Bailey, an 
early LSD experience became associated with anxiety in his memory and as such he developed 
an information structure in which drugs are associated with fear. It was an environmental factor, 
a drug experience, which became associated with anxiety and in turn produced chronic OCD. 
Brain structure 
A characteristic pattern of activation in the brain structures of patients may predict the 
onset of OCD. Rauch, Jenike, Alpert, Baer and colleagues (1994) demonstrated that activation in 
the orbitofrontal cortex, caudate nucleus, and anterior cingulate cortex is associated with worry 
in the brains of OCD patients. Rauch and colleagues (1994) found this activation by provoking 
symptoms in patients with OCD using a stimulus of their own choice such as a contaminated 
object. Once patient’s symptoms had been provoked, their patterns of brain activation were 
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measured using positron emission tomography (PET). Oxygen-15 labeled carbon dioxide, a 
radioactive pharmaceutical, was used to trace patterns of brain activation. Patients whose 
symptoms had been provoked showed enhanced activation in the bilateral orbitofrontal cortex 
(OFC), left anterior cingulate cortex, and right caudate nucleus compared to the same group of 
patients before symptom provocation. This finding indicates that these brain structures are 
involved in the process of worry in patients with OCD. There is more to the biology behind OCD 
than brain structure alone. Neurotransmitters and genetics both play a role in the development of 
the disorder. 
What is a neurotransmitter? 
 
A dysregulation in the neurotransmitters serotonin and dopamine is one of the 
demonstrated etiologic underpinnings of OCD. What is a neurotransmitter, how are they 
assessed, and why are they important in the genesis of OCD? Neurotransmitters are the chemical 
messengers of the nervous system. There are many different types of neurotransmitters, each of 
which perform a different set of functions and are present in varying quantities in different parts 
of the brain. In order for a substance to be classified as a neurotransmitter it must endorse two 
criteria: (1) “The proper nerve trunk or set of nerve axons can be selectively stimulated” to 
release the substance and (2) the “release of the transmitter can be detected in the amounts 
released by single nerve endings after one action potential” (Cooper et al., 2003, p.31). The 
neurotransmitters dopamine and serotonin (5-HT) are the two neurotransmitters implicated in the 
development of OCD. (da Rocha et al., 2008, Flaisher-Grinberg et al., 2008, Kontis et al., 2008) 
Dopamine was originally thought to be a precursor to norepinephrine until it “was 
recognized as a transmitter in its own right” (Hökfelt, Johansson, & Goldstein, 1984, p.1328).  
Dopaminergic neurons are located primarily in the “mid and rostral parts of the brain--that is, in 
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the mesencephalon (mid brain), hypothalamus (hormones), and olfactory bulb (smell), with 
scattered cells in some other brain regions” (Hökfelt, Johansson, & Goldstein, 1984, p.1328).  
The mesencephalon contains the substantia nigra, a brain region associated with the development 
of Parkinson’s disease. The substantia nigra produces dopaminergic neurons which are 
transmitted to the stiatum. Parkinson’s patients do not produce as many dopaminergic neurons in 
the substantia nigra which leads to less dopamine in the striatum, the major input to the basal 
ganglia which is the brain region responsible for movement. This demonstrates the importance of 
dopamine for voluntary movements. (Cooper et al., 2003, p.225) 
Serotonin (5-HT) is one of the best understood neurotransmitters. Serotonin “nerve 
terminal networks” have been discovered in “virtually all parts of the brain” (Hökfelt, Johansson, 
& Goldstein, 1984, p.1328). Assessment of serotonin was challenging until “Steinbusch et al. 
used antibodies to 5HT conjugated with bovine serum albumin to visualize the 5HT systems in 
an easy and reproducible way” (Hökfelt, Johansson, & Goldstein, 1984, p.1328). This technique 
allows for serotonin in the brain to be easily tracked and identified. Because of the “widespread 
projections and highly regulated pacemaker pattern of activity that is characteristic of serotonin 
neurons, a broad homeostatic function has been suggested for serotonergic systems” (Cooper et 
al., 2003, p.291) In other words, serotonin is responsible for so many sensory and motor 
functions that it is difficult to characterize its role in simple terms. Dysregulation of serotonin 
can lead to a wide variety of disorders. The development of OCD is the one disorder this paper is 
focused on. 
What is a genetic marker? 
 
All genetic variation in the population is the result of mutation. Mutations occur 
randomly in individuals at some point along a particular chromosome. Mutations are then 
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inherited through generations which lead to the expression of a particular phenotype, in this case 
the development of OCD. In order to locate a particular mutation on a chromosome such as a 
mutation which causes OCD, genetic markers are used. Genetic markers are particular points 
along a chromosome which can be assayed for (identified using biological testing). When 
gametes (sex cells) undergo meiosis (cell division) during sexual reproduction, chromosomal 
crossover occurs where sections of one chromosome are split and linked up with sections of 
another chromosome. Genetic linkage describes the proclivity for two genetic markers which are 
physically close together along a chromosome to be inherited together. In other words the chance 
of those two genetic markers getting separated during the crossover which occurs during meiosis 
is very slim. Linkage can be used as a way of locating a particular mutation along a 
chromosome. If the mutation is consistently inherited along with two genetic markers which are 
linked (physically close together), one can deduce that the mutation must occur at some point 
between those two markers, otherwise the mutation would have been separated from those 
markers during meiosis. It is important to note that mutations occur randomly and may develop 
at any point on a chromosome. Genetic linkage describes the method for locating a particular 
mutation, such as one which may manifest as OCD. (Strachan & Read, 1999). 
Scope of Project 
 
Attempting to empirically demonstrate the exact genetic and neurochemical mechanisms 
which cause the development of OCD is a tall order and one that is truly out of my grasp. The 
empirical research required to answer this question would require resources far beyond what I 
have at my disposal. What I do have at my disposal is the cutting edge research into this question 
from scholars at the forefront of their field. Therefore, in order to address my topic, I will review 
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current literature on the genetic and neurochemical etiology of OCD from empirical journals and 
books in the hopes of drawing biologically based conclusions about the underpinnings of OCD. 
Some of the research into the etiology of OCD is well established. The environmental 
and psychosocial predictors of OCD, as well as several of the brain structures involved, have 
been studied extensively. However, the neurochemical and genetic underpinnings of OCD are 
not as well understood, and a burgeoning degree of research into the etiology of OCD over the 
past decade concerns these topics. Research concerning the role of the neurotransmitters 
serotonin and dopamine in the etiology of OCD comprises a large percentage of my project 
because patients with OCD display irregular levels of these neurotransmitters. Research 
concerning genetic markers for OCD also makes up a large percentage of my project because 
these markers potentially hold the key to predicting the onset of the disorder. These two areas of 
research converge in several studies concerning the serotonin transporter (5-HTT) gene which 
may play a pivotal role in the etiology of OCD. The areas of research above consist of the scope 
of the studies included in my project. 
Much of the recent research into OCD is about comorbidity, course, and treatment of the 
disorder. Studies concerning these topics were not included in my project because my research 
question concerns the etiology of OCD and the neurotransmitters and genes associated with the 
disorder. Comorbidity studies confound my research topic because any etiologic factors 
identified could be attributed to the comorbid disorder. Studies concerning the course of OCD 
and treatment were excluded from my project because I am concerned with how and why the 
disorder develops which is a different question from how best to treat an active case of OCD. 
My research question is ultimately what dictates the scope of my project. My question is: 
what are the neurochemical and genetic underpinnings of obsessive-compulsive disorder? This 
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question is broad enough to include a variety of theories on the etiology of OCD and it is 
simultaneously specific enough to limit the scope of my project to be achievable within the 
relatively short amount of time I have to complete it. 
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Chapter Two 
Neurochemical Underpinnings of OCD 
 Neurochemicals are the chemical messengers of the brain. Whenever any brain activity 
occurs, it is the result of a chemical message. There are many different types of 
neurotransmitters; however, the two that I will be focusing on for the sake of this review are 
serotonin and dopamine because these are the two neurotransmitters whose dysfunction is 
implicated in OCD. Neurotransmitter dysfunction is currently believed to be the leading 
biological explanation for the development of OCD. 
Serotonin 
Selective Serotonin Reuptake Inhibitors (SSRIs) 
 There is a substantial body of evidence suggesting serotonin has a role in the etiology of 
OCD. Some of the strongest evidence for serotonin’s role comes from studies investigating the 
mechanisms behind selective serotonin reuptake inhibitors (SSRIs), the primary pharmacological 
treatment for OCD. Several studies have investigated the mechanisms and role of SSRIs in the 
etiology of OCD (El Mansari & Blier, 2006; Mavorgiorgou et al., 2010). 
 El Mansari & Blier (2006) investigated the state of research on OCD medication. Their 
article reviewed the chemical action of SSRIs as well as the mechanisms underlying those 
actions. In their review, the authors first elucidate the effects of SSRIs on 5-HT 
neurotransmission. Upon first starting SSRI or MAOI treatment, patients experience a reduction 
of the firing activity of serotonin neurons. This initial reduction is followed by a recovery 
process in which, after the first two weeks, patients experience symptom relief simultaneous with 
an increase in synaptic 5-HT. SSRIs desensitize 5-HT autoreceptors (presynaptic receptors) and 
trick the neuron into thinking that less serotonin is being transmitted in each action potential than 
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is actually the case. The neurons then compensate by firing more 5-HT in each action potential. 
The authors also point out that SSRI treatment takes longer to take effect in OCD patients than in 
depressive patients. They suggest that this is because it takes SSRIs eight weeks to desensitize 5-
HT autoreceptors in the OFC, a brain region associated with OCD, compared with only four 
weeks for the medication to desensitize 5-HT autoreceptors in the frontal cortex and 
hypothalamus. They also suggest that higher doses may be required to obtain this same 
desensitization effect in OCD patients. The authors go on to show that the desensitization of 5-
HT autoreceptors in the OFC actually causes a desensitization of the postsynaptic 5-HT1A 
receptor but not the 5-HT2A or 5-HT2C receptors. Based on this finding the authors suggest that 
activation of the 5-HT2 receptors is partially responsible for the symptom reduction produced by 
the effect of the greater 5-HT release in the OFC of OCD patients. This makes sense in light of 
findings that hallucinogens which act as 5-HT2 receptor agonists provide symptom relief in OCD 
patients. These findings suggest that the beneficial action of SSRIs is at least partially mediated 
by the activation of postsynaptic 5-HT2 receptors. 
 A recent study by Mavorgiorgou and colleagues (2010) hypothesized that OCD patients 
were typified by a strong loudness dependence of auditory evoked potentials (LDAEP) of the 
primary, not secondary, auditory cortex, which would indicate low serotonergic function. 
LDAEP is an established method of measuring serotonergic function. LDAEP is inversely 
correlated with serotonergic function meaning the higher the LDAEP, the lower the serotonergic 
function. The authors measured LDAEP in patients with OCD before and after a ten week 
treatment with sertraline, better known as Zoloft, an SSRI, and compared them with a group of 
healthy controls. The authors found that the LDAEP of the primary auditory cortex of OCD 
patients without medication was significantly higher than healthy controls. Furthermore, the 
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LDAEP of primary auditory cortex was significantly lower in OCD patients after treatment with 
sertraline, as were their OCD symptoms compared with baseline. These results support the 
notion that OCD is characterized by serotonergic dysfunction, which SSRIs may correct. 
 Taken together, El Mansari & Blier (2006) and Mavorgiorgou and colleagues (2010) put 
forth a strong case that the mechanisms underlying the therapeutic success of SSRIs are linked to 
the mechanisms which underlie OCD. El Mansari & Blier’s (2006) discussion of the 
desensitization of 5-HT autoreceptors elucidates the pharmacological action of SSRIs. Together 
with the findings in the next section which discuss the beneficial effects of 5-HT2A psychedelic 
drugs, a strong case is suggested that activation of 5-HT2 receptors is associated with therapeutic 
effects on OCD. Mavorgiorgou and colleagues’ (2010) study used LDAEP as a measure of 
serotonergic function to provide empirical evidence that OCD is characterized by serotongeric 
dysfunction and that SSRIs improvement of serotonergic function may represent the mechanism 
underlying their therapeutic effect upon OCD patients. 
5-HT2A Psychedelic Drugs 
 Additional evidence for serotonin’s role in the etiology of OCD comes from studies 
investigating the administration of psychedelic drugs to patients with OCD (Zghoul & Blier, 
2003; Moreno et al., 2006). 
 Zghoul & Blier (2003) suggest that LSD has an enhancing action on the responsiveness 
of neurons in the OFC to 5-HT. It has been well established that the availability of 5-HT to 
neurons in the OFC is a mediating factor in the severity of OCD. The authors administered 5-HT 
and LSD to patients with OCD via microiontophoresis, a process used to measure neuronal 
responsiveness to an ejected substance. Microiontophoresis uses a micro pipette with multiple 
barrels, one for the LSD, one for 5-HT, and one for a saline solution. In the experimental 
OCD Etiology 17 
 
condition, the LSD was ejected first, then the 5-HT, the saline solution followed. The neurons 
reaction to the saline solution provides a measurement of responsiveness produced by the 5-HT. 
The authors then followed up with a control condition in which only 5-HT and saline solution 
were included. If the neurons were more responsive after the LSD condition compared with the 
control condition, then the LSD increased those neurons responsiveness to 5-HT.  The authors 
conducted this procedure first on the OFC, then on the hippocampus, a brain structure associated 
with depression. They found that the LSD made neurons significantly less responsive in the 
hippocampus but it did make them more responsive in the OFC. This finding indicates that LSD 
has an enhancing action on 5-HT in the OFC, a brain region associated with OCD. This study 
was one of the first to provide neurological evidence for hallucinogenic drugs’ beneficial effects 
on OCD symptoms. 
 Several years later, Moreno and colleagues (2006) investigated the safety, tolerability, 
and efficacy of psilocybin on nine patients diagnosed with OCD. While Zghoul & Blier (2003) 
were searching for a neurological basis for hallucinogens’ beneficial effects on OCD, Moreno 
and colleagues (2006) examined the actual effectiveness and safety of using these drugs in a 
clinical setting. Psilocybin is the psychoactive drug found in the most commonly used 
hallucinogenic mushrooms. The authors were interested in experimenting with psilocybin as a 
treatment for OCD after hearing of several anecdotal reports in the literature of reduction of 
OCD symptom severity while individuals were under the influence of these drugs. It has already 
been well established that these drugs exert their effects through agonizing 5-HT1A, 5-HT2A, and 
5-HT3A receptors and that increasing synaptic 5-HT may be the pathway through which SSRI 
treatments exert their effects. Following from these two findings, the authors hypothesized that 
treatment with psilocybin would decrease symptoms in a sample of patients with OCD. The 
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author’s results indicate that all nine patients tolerated the procedure well and experienced a 
statistically significant decrease in their OCD symptoms as measured by the Yale-Brown 
Obsessive Compulsive Scale (YBOCS). These findings indicate that the serotonergic action of 
psilocybin affected the severity of patients’ OCD symptoms providing further proof for 
serotonin’s role in OCD. 
 These two studies provide empirical evidence that hallucinogenic drugs, which act as 5-
HT2A receptor agonists, exert anti-OCD effects on those afflicted with the disorder. Zghoul and 
Blier (2003) found that LSD has an enhancing effect on the action of serotonin in the OFC, a 
brain region implicated in OCD. This finding indicates that the anti-OCD effect produced by 
LSD is mediated through its serotonergic effects on the OFC. This suggests that OCD is caused 
by an inherent dysfunction in serotonin. Moreno and colleagues (2006) found that psilocybin was 
tolerated well by a sample of patients with OCD and produced a statistically significant reduction 
in their OCD symptoms as measured by YBOCS. This finding suggests that 5-HT2A agonists 
may prove to be a novel target for drug treatments for OCD. Psilocybin exerted its anti-OCD 
effects as soon as the drug took effect and the decrease in symptoms outlasted the effects of the 
drug. These findings propose that hallucinogenic drugs may be a better treatment than SSRIs 
which can take up to eight weeks to take effect and often require increases in dose to achieve 
similar anti-OCD effects.  While it seems impractical to administer hallucinogens to OCD 
patients regularly for treatment, these findings suggest that the 5-HT2A receptor which these 
drugs agonize may be a potential target for new OCD medication. 
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Serotonin Transporter (5-HTT) 
Recent studies have implicated a dysfunction in the serotonin transporter (5-HTT) as a 
hypothetical etiologic underpinning of OCD (Stengler-Wenzke et al., 2004; Hasselbalch et al., 
2007; Zitterl et al., 2007; Shanahan et al., 2009; Matsumoto et al., 2010). Stengler-Wenzke and 
colleagues (2004) conducted one of the earlier studies to investigate the role of 5-HTT in the 
etiology of OCD using new imaging technology. They propose that patients with OCD will 
display a reduction in 5-HTT availability in the midbrain, brainstem, and thalamus. In order to 
answer this question, the authors used a magnetic resonance imaging (MRI) technique called 
single-photon emission computed tomography (SPECT), a technique using gamma rays, and 
statistical analysis. SPECT imaging uses radioligands, substances used in research which bind to 
neurotransmitter receptors and imitate the neurotransmitter. Their results indicate a statistically 
significant reduction in ten OCD patient’s 5-HTT availability in the midbrain and upper 
brainstem compared with a group of healthy controls. This result suggests a decreased number of 
serotonergic neurons in the brains of OCD patients compared with healthy controls. This would 
explain why administration of SSRIs is an established clinical treatment for OCD. The authors 
suggest that this reduced availability of serotonin is most likely genetically predisposed in 
patients with OCD. 
 Three years later, Hasselbalch and colleagues (2007) took this question a step further and 
suggested that patients with OCD have a reduced binding potential (BP) for 5-HTT in the 
midbrain. The authors used SPECT imaging and statistical analysis and found that OCD patients 
had a reduced 5-HTT BP in the midbrain-pons compared to healthy controls. They did not find a 
correlation between this reduced 5-HTT BP and similar reductions in clinical variables which 
they attribute to the small sample size. This study adds further evidence to the 5-HTT 
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dysfunction hypothesis of OCD by implicating reduced binding potential in the midbrain-pons as 
a possible underpinning of OCD. 
 In the same year, Zitterl and colleagues (2007) sought to investigate serotonergic function 
in the thalamus/hypothalamus of compulsive checkers. The authors used SPECT imaging and 
statistical analysis to measure the availability of 5-HTT in the thalamus/hypothalamus region. 
The authors conducted their study with a sample of 24 patients diagnosed with OCD and found 
statistically significant reduced 5-HTT availability in the thalamus/hypothalamus region of the 
compulsive checkers when compared with a sample of 24 healthy controls. This study adds 
further support to the 5-HTT dysfunction hypothesis of OCD by implicating reduced 5-HTT 
availability in the thalamus/hypothalamus as a potential underpinning of the disorder. 
 Two years later, Shanahan and colleagues (2009) used prepulse inhibition (PPI) as a 
measure of compulsive behavior in mice to conduct their study on the reduction of 5-HTT 
availability in OCD. PPI is a measure of the diminishing of the startle response when a barely 
detectable prepulse precedes the stimulus by 30-500ms. The idea is that PPI provides a measure 
of an individual’s ability to filter out excess stimulation. Individuals with some psychological 
disorders such as schizophrenia and OCD have lower PPI than healthy controls. In their study, 
the authors used PPI as a measure for compulsive behavior in rodents and treated mice with 5-
HT1B agonists, which mimic compulsive behavior. The authors theorized that by reducing 5-HTT 
function in mice, either by breeding mice with deficient 5-HTT genes or extended administration 
of SSRIs, the PPI deficit caused by administration of 5-HT1B agonists would diminish. Thus, the 
authors created a model for compulsive behavior in mice and then attempted to treat that 
compulsive behavior with either SSRIs or genetics. The author’s results supported their 
hypothesis. 5-HT1B agonists increased compulsive behavior and created a PPI deficit in mice, 
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and the authors were able to correct this deficit by breeding mice with reduced 5-HTT gene 
expression or chronic administration of SSRIs. This study lends further support to the 5-HTT 
hypothesis of OCD etiology through a different model (PPI). These authors also investigated a 
possible genetic predisposition for OCD through breeding 5-HTT deficient mice to measure their 
compulsive behavior compared to controls. 
 One year later, Matusumoto and colleagues (2010) conducted an additional study on the 
BP of 5-HTT. Their study focused on the insular cortex (disgust emotion) of patients and used a 
radioligand with a higher binding potential for serotonin receptors than previous studies. The 
authors found the expected reduced BP in the insular cortex of OCD patients compared with 
healthy controls. They did not find lower BP in brain regions rich in 5-HTT such as the 
midbrain, thalamus, and striatum; all areas which other research has implicated. The authors 
attribute these discrepancies to their relatively small sample size and use of a different 
radioligand from other studies. Further research will have to be conducted to account for these 
inconsistencies and further examine 5-HTT availability in all of these brain regions. 
 All of the above studies, apart from Shanahan and colleagues (2009) used SPECT 
imaging and statistical analysis to measure 5-HTT dysfunction in different brain regions. 
Stengler-Wenzke and colleagues’ (2004) study suggests that decreased 5-HTT availability in the 
midbrain, brainstem, and thalamus is associated with OCD. Hasselbalch and colleagues’ (2007) 
study posits decreased BP for 5-HTT in the midbrain-pons is associated with OCD. Zitterl and 
colleagues’ (2007) study proposes that decreased 5-HTT availability in the 
thalamus/hypothalamus region is associated with OCD. Matsumoto and colleagues’ (2010) study 
suggests decreased BP for 5-HTT in the insular cortex is associated with OCD. Shanahan and 
colleagues (2009) was the only one of these studies to use a different measure of 5-HTT 
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function. They used PPI and a 5-HT1B receptor agonist to measure and model OCD and an SSRI 
to treat the model OCD. Their study also suggests that 5-HTT dysfunction is linked with OCD. 
Taken together, all of these studies make a strong case for decreased 5-HTT in various brain 
regions as a potential neuroanatomical model of OCD. Some studies did not find decreased 5-
HTT in the other brain regions which other studies implicated. This is most likely due to sample 
size and statistical error. Nevertheless a more thorough investigation of 5-HTT across all of the 
brain regions implicated in the development of OCD is necessary before conclusions can be 
drawn about 5-HTT availability as an etiologic factor in OCD. 
Dopamine 
 There is a large body of evidence suggesting a role for serotonin in the etiology of OCD. 
However, a few studies have also suggested a role for dopamine in the etiology of OCD (Kim et 
al., 2007; Olver et al., 2009). Kim and colleagues (2007) suggest that serotongeric drugs such as 
SSRIs may alter dopamine function in the striatum of patients with OCD and that this change 
could be associated with OCD symptoms. In order to investigate this question, the authors used 
SPECT to measure the density of the dopamine transporter (DAT) in the basal ganglia of patients 
with OCD before and after treatment with an SSRI. Their results indicate a significant decrease 
in DAT binding in the right basal ganglia (RBG) of patients after treatment with an SRI. In 
addition a relationship was observed between the decrease in DAT binding in the RBG and a 
decrease in compulsive symptoms of patients. These results suggest that a dysregulation in the 
functioning of dopamine in the basal ganglia may be responsible for OCD symptoms, and that 
medication which can correct this dysfunction may be responsible for improvement in OCD 
symptoms. 
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 Olver and colleagues (2009) investigated the role of dopamine acting on the D1 receptor 
in the striatum (input to basal ganglia) of patients with OCD. The authors proposed that 
dopamine in the striatum of patients with OCD may have a role in regulating OCD symptoms. 
They used positron emission tomography (PET) scans to measure the binding potential (BP) of a 
D1 antagonist in the striatum of patients with OCD and healthy controls. Their results indicate a 
decrease in BP of the D1 antagonist in both sides of the caudate nucleus and the putamen (the 
two sectors in the striatum). A decrease in dopamine binding potential in the striatum makes 
sense considering that a dysfunction in the cortico-striatal-thalamic pathways of the brain is one 
of the established neuroanatomical models for OCD. 
 Taken together, Kim and colleagues (2007) and Olver and colleagues (2009) suggest that 
greater binding potential of the dopamine transporter in the striatum of OCD patients may result 
in more severe OCD symptoms. This problem can be corrected through treatment with SSRIs 
which increase the amount of serotonin in the synapse, which in turn decreases binding of 
dopamine. This finding seems to suggest that the origin of the dopaminergic dysfunction in OCD 
actually lies in an imbalance of the serotonin system. 
Neurochemical Summary 
 The studies reviewed in this section propose several different pathways through which 
neurochemical dysfunction may lead to the development of OCD. Evidence from studies 
investigating the therapeutic effects of SSRIs suggest that because SSRIs desensitize many 
serotonin receptors yet not the 5-HT2 receptors, activation of this receptor type may be 
responsible for these medication’s beneficial effects in treating OCD. Evidence from studies 
investigating the effects of 5-HT2A hallucinogens provide further support that activation of these 
serotonin receptors may be responsible for the therapeutic effect of SSRIs and that novel OCD 
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drugs might specifically target these receptors. Studies examining the role of 5-HTT in the 
etiology of OCD provide evidence that 5-HTT dysfunction in several brain regions implicated in 
OCD may be responsible for the development of the disorder and that patients with OCD may be 
genetically predisposed to 5-HTT dysfunction. Finally, studies investigating the role of 
dopamine in OCD found that greater binding potential for DAT in the striatum of patients may 
result in greater symptom severity. However, these studies suggest that because this dysfunction 
can be corrected with SSRIs by increasing the amount of serotonin in the synapse, the source of 
this dysfunction probably lies in the serotonin system. 
Neurochemical Critique 
 The studies reviewed in this section provide a wealth of evidence that neurochemical 
dysfunction, especially in the serotonin system, may be responsible for the etiology of OCD. 
However, these studies are not definitive and leave plenty of room for improvement. Because 
drugs used to treat OCD such as SSRIs were discovered prior to the identification of the 
biological basis for the disorder, researchers have assumed that the mechanisms underlying these 
drugs must be related to the dysfunction inherent in the disorder. However, SSRIs work by 
drastically increasing serotonin in the synapse, leaving the exact mechanism through which this 
effect works to alleviate OCD unknown. 
 Evidence from the beneficial effects of 5-HT2A hallucinogenic drugs on OCD suggest 
that activation of these serotonin receptors may be the mechanism through which SSRIs are 
relieving OCD symptoms. While the two studies cited investigating these drugs do provide 
evidence that hallucinogens do relieve OCD symptoms through increasing neuronal 
responsiveness to serotonin and that the experience is well tolerated and effective on human 
probands, they leave open the question of how exactly this knowledge can be applied. It seems to 
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me that by finding or designing a drug which selectively activates 5-HT2 receptors without 
causing the disruptive cognitive effects of hallucinogenic drugs, one might be closer to a more 
effective treatment for OCD. 
 The studies investigating the role of 5-HTT in the etiology of OCD provide evidence that 
5-HTT dysfunction in brain regions implicated in OCD may be partially responsible for the 
development of the disorder. These studies, apart from Shanahan and colleagues (2009) all used 
SPECT imaging and statistical analysis to determine whether patients with OCD had 
significantly reduced binding potential for 5-HTT in several different brain regions. While their 
findings do suggest that reduced 5-HTT BP is an etiologic factor in the disorder, their results 
conflict with each other and none of the studies carries enough statistical power to determine 
with confidence whether these dysfunctions are a root cause of OCD. Future research is needed 
to determine the exact nature of this 5-HTT dysfunction, including the genes responsible for the 
dysfunction, in order for this research to have a practical application in managing the disorder. 
 The studies reviewed concerning dopamine provide support that over activity of 
dopamine is associated with compulsive symptoms of OCD. While these findings are compelling 
and point to a neurochemical basis for these behaviors, they ultimately suggest that because 
treatment with SSRIs corrects this surplus of dopamine, the etiologic basis of this imbalance lies 
in serotonergic dysfunction. This suggests that the increased BP for DAT is a symptom rather 
than a cause of OCD. While this research is intriguing it suggests that future research on the 
etiology of OCD should concern itself with serotonin, not dopamine. 
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Chapter Three 
Genetic Underpinnings of OCD 
 Genes refer to specific loci on chromosomes which code for aspects of the biology of an 
organism. Humans inherit their genetic makeup from their parents and pass on their genes 
through Mendelian inheritance, a process of recombination which passes on some genes from the 
mother and others from the father. While neurochemistry and genetics are both searching for 
biological explanations of OCD, there is a fundamental difference between the two. 
Neurochemical underpinnings refer to the dysfunction within the brain of an individual which is 
responsible for OCD. Genetic underpinnings refer to the abnormal genes which an individual 
inherited from their parents which are responsible for the neurochemical dysfunction thought to 
underlie OCD. 
Family and Twin Studies 
Several studies have demonstrated familial inheritance of OCD (Clifford et al., 1984; 
Pauls & Alsobrook, 1999; Hasler et al., 2007; van Groothest et al., 2007; Wilcox et al., 2008; 
Katerberg et al., 2010). Clifford and colleagues (1984) conducted one of the earliest twin studies 
comparing samples of Monozygotic (MZ) and dizygotic (DZ) twins to investigate the heritability 
of obsessional traits and symptoms. They found that just under half of the differences in two 
scales of obsessional symptoms and traits could be attributed to familial inheritance indicating a 
potential genetic contribution to the development of OCD. It would be many years before studies 
were published which replicated and built on the findings of Clifford and colleagues (1984). 
Sixteen years after Clifford and colleagues (1984), Pauls and Alsobrook (1999) 
concluded that because no twin studies had been published to replicate the findings of Clifford 
and colleagues (1984), the degree of genetic control over OCD was still uncertain. The authors 
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posited that family and twin studies into the etiology of OCD can only advance the field’s 
knowledge to a certain extent. They suggested that the future of research into the inheritance of 
OCD lies in studies of genetic linkage which can help locate the exact genes which cause the 
development of the disorder. Future twin studies investigating the etiology of OCD would focus 
not only on the heritability of OCD but of specific OCD symptom dimensions.  
Several years later, Hasler and colleagues (2007) found that certain clusters of OCD 
symptoms are particularly heritable. These authors used the YBOCS symptom dimensions and 
found that hoarding obsessions and compulsions, as well as aggressive, sexual, religious, and 
somatic obsessions and checking compulsions were the most familial symptom categories. These 
results indicate that certain subtypes of OCD are more likely to run in families than other 
subtypes.  
Van Grootheest and colleagues (2007) investigated the stability, as well as the genetic 
and environmental influences of obsessive-compulsive (OC) behavior in children. These authors 
found that OC behavior was moderately stable in children between the ages of seven and twelve 
and that the stability of OC behavior was influenced by genetics, as well as by shared and non-
shared environmental factors. The stability of OC phenotypes in children were rated by both the 
mother and father separately in order to determine which behaviors parents agreed upon and 
which they differed on. The findings of this study suggest that genetic and environmental factors 
combine to predict the development of OC symptoms in children. 
Wilcox and colleagues (2008) found that certain aspects of parental behavior contributed 
to the development of OCD in children. Maternal and paternal care, overprotection, and control 
were the three factors tested in the study. The authors found that maternal and paternal 
overprotection were associated with the development of OCD in offspring, whereas paternal care 
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was found to be a protective factor. Upon further analysis it was found that these results only 
proved true when neither parent were diagnosed with OCD themselves. Paternal care as a 
protective factor proved to be the only result which remained true after further analyses were 
performed. 
Katerberg and colleagues (2010) used the largest sample size yet for an OCD symptom 
dimension study and found that OCD and its individual symptom dimensions are heritable. Their 
results also suggest that the particular genes which are believed to put individuals at risk for 
OCD in general are different from the genes which make individuals susceptible to separate 
symptom dimensions. These results further support the notion that there is a genetic component 
to both OCD and to the various ways the disorder can manifest in different individuals. 
All of these studies provide familial evidence for the inheritance of OCD. However, as 
Pauls and Alsobrook (1999) pointed out, the limitations of all of these studies is the lack of 
evidence pointing to the specific gene or genes responsible for the disorder. Clifford and 
colleagues (1984) were the first to point out that OCD runs in families and twins. Van 
Grootheest and colleagues (2007) and Wilcox and colleagues (2008) both identified 
environmental influence as a key factor in determining heritability of OCD in families and twins. 
Hasler and colleagues’ (2007) study suggests that certain clusters of OCD symptoms are 
inherited together. Katerberg and colleagues (2010) brought all of this research together and 
found that OCD as well as certain OCD symptom dimensions are inheritable and the particular 
genes responsible for OCD in general are different from those regulating the expression of 
certain symptom dimensions. Twin studies can be useful in identifying the heritability of a 
particular disorder; however, they do not bring the field much closer to locating the genes 
responsible for the disorder. 
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White Matter Studies 
 Several studies have suggested that white matter abnormalities in the brain structures of 
individuals with OCD may be involved in the etiology or pathogenesis of the disorder (Garber et 
al., 1989; Jenike et al., 1996; Szeszko et al., 2005; Stewart et al., 2007; Nakamae et al., 2008; 
Atmaca et al., 2010). White matter is a term which describes axons (shafts of neurons) which are 
covered in myelin sheath (fatty tissue which speeds transmission of signals). This is as opposed 
to grey matter which contains the cell bodies of neurons. 
 Garber and colleagues (1989) were the first researchers to identify white matter 
abnormalities as predictors of OCD. The authors took MRI scans of 32 OCD patients and 14 
healthy controls and found frontal lobe white matter differences in the scans of OCD patients 
compared with control group. In addition, these differences were correlated with severity of 
OCD symptoms. 
 It would be seven years before Jenike and colleagues (1996) would build on the results of 
Garber and colleagues (1989). These authors conducted an MRI study comparing the brains of 
10 women diagnosed with OCD with 10 healthy age-matched controls. They found significantly 
less white matter in the postero-inferior periocallosal, retrocallosal, and cerebellar regions of the 
brains of women diagnosed with OCD. The callosal brain regions surround the corpus callosum, 
the bundle of neurons which binds the two halves of the brain together, while the cerebellum 
(latin for little brain) is a region located in the lower rear of the brain responsible for balance and 
motor control. Less white matter means less myelin which means slower transmission of neural 
signals in the affected brain regions. Several studies have since replicated the findings of Garber 
and colleagues (1989) and Jenike and colleagues (1996) but it would be nine years before new 
technology would allow research on white matter to progress further. 
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 Szeszko and colleagues (2005) used an MRI technique called diffusion tensor imaging 
(DTI) to measure the diffusion of water in brain tissue in order to produce neural tract images. 
This technique allows the researchers to determine the degree of anisotropy, or directionality of 
diffusion across myelinated axons. The output of this investigation is a value called a fractional 
anisotropy (FA) which varies from zero to one. A value of zero indicates that the diffusion is 
isotropic, meaning diffusion is unrestricted in all directions. A value of one indicates that 
diffusion is only occurring along a single axis and is restricted in all other directions. The authors 
found significantly lower FA in three white matter areas of the anterior cingulate gyrus, one of 
the brain regions associated with OCD. In addition, the authors also found lower FA in other 
areas of the brain and did not find higher FA in any white matter areas of the brains of OCD 
patients compared with healthy controls. 
 Stewart and colleagues (2007) conducted a family-based gene association study to 
determine whether the gene which codes for Oligodendrocyte lineage transcription factor 2 
(OLIG2) could be responsible for the transmission of OCD. OLIG2 helps regulate the 
development of oligodendrocyte cells which produce white matter. Abnormalities in white 
matter have been associated with OCD. Therefore, polymorphisms in the OLIG2 gene could be 
the etiological link which leads to the development of abnormalities in white matter which are 
associated with the presence of OCD. The authors found the suspected polymorphisms in the 
OLIG2 gene only in the patient samples that had OCD without comorbid Tourette’s disorder. 
This finding indicates that the development of white matter abnormalities may be specifically 
linked to the “pure” OCD phenotype without comorbidity.  
 Nakamae and colleagues (2008) used DTI to measure FA and apparent diffusion 
coefficient (ADC) of fifteen patients with OCD compared with fifteen healthy controls. ADC 
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represents another method of measuring the degree of diffusion throughout neural tracts in DTI. 
The authors found higher FA in the white matter of the bilateral semioval center extending to the 
subinsular cortex as well as higher ADC in the white matter of the left medial frontal cortex. 
These brain areas are commonly associated with the emotion of disgust suggesting that disgust 
may play an important role in the pathogenesis of OCD. 
 Atmaca and colleagues (2010) used genotyping and MRI techniques to determine 
whether a polymorphism of the myelin oligodendrocyte glycoprotein is associated with volume 
of white matter in patients with OCD. The authors found larger white matter volumes in patients 
with OCD compared with healthy controls and found that the aforementioned polymorphic 
genotype was associated with a diagnosis of OCD. These findings provide evidence that a 
polymorphism of the myelin oligodendrocyte glycoprotein might be associated with higher 
volumes of white matter in the brains of patients diagnosed with OCD. 
 All of these studies provide evidence that white matter abnormalities exist in the brains of 
OCD patients. Garber and colleagues (1989) were the first to discover differences in white 
matter in the brains of OCD patients compared with healthy controls. Szeszko and colleagues 
(2005) and Nakamae and colleagues (2008) used new MRI technique DTI to measure 
directionality and nature of white matter differences in specific regions of the brain which further 
developed the white matter findings in OCD patients. Stewart and colleagues (2007) conducted a 
study to find the genetic basis for these white matter differences and found it in the OLIG2 gene. 
Atmaca and colleagues (2010) combined the two halves of this research by conducting a study 
which used genotyping for the oligodendrocyte gene to identify the genetic polymorphism 
responsible for the white matter abnormalities as well as MRI techniques to identify the 
abnormalities themselves. 
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Genetic Markers 
 Several studies have taken advantage of recent innovations in genetics which have 
allowed researchers to hone in on specific genes which may be implicated in the transmission of 
OCD. (Shugart et al., 2006; Wang et al., 2009; Voyiaziakis et al., 2011) Shugart and colleagues 
(2006) conducted the first large scale study to search for specific genetic loci which may put 
individuals at risk for developing OCD. Their study was part of the OCD Collaborative Genetics 
study (OCGS), conducted at six sites including 219 families affected with OCD. The authors 
used scans for genetic linkage across each chromosome to find specific points along any 
chromosome which were consistently inherited in families of patients with OCD. The authors 
found regions on chromosomes 1, 3, 6, 7, and 15 which showed evidence of linkage with 
particularly strong support of linkage on chromosome 3. The region on chromosome 3 
implicated in the study, 3q27-28, is of particular interest because it includes the location of three 
candidate genes, 5HTR3C, 3D, and 3E, all of which are serotonin receptor-like genes. A 
dysregulation of serotonin is one of the proposed mechanisms for the pathogenesis of OCD in 
the brain which makes this finding particularly salient. While Shugart and colleagues (2006) 
found some evidence suggesting genetic heritability of OCD, they did not find significance for 
linkage on any of the chromosomes. The authors suggest that future studies could use more 
advanced statistical techniques and larger sample sizes in order to narrow down the search for 
candidate genes in OCD. 
 Wang and colleagues (2009) used blood sampling and statistical analyses to determine 
whether there was an association between expression of the catecholamine-o-methyl-transferase 
(COMT) gene and OCD. They found an abnormally low expression of the COMT gene in the 
blood of OCD patients compared with healthy controls. This makes sense in light of the finding 
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that COMT is important in regulating the amount of dopamine and other catecholamines in the 
prefrontal cortex. Dysregulation of these neurochemicals in the prefrontal cortex is associated 
with OCD.  
 Voyiaziakis and colleagues (2011) used the OCGS sample to investigate whether 
SLC6A4, the 5-HTT gene, was genetically associated with the development of OCD. These 
authors genotyped 1241 DNA samples from the OCGS and applied several statistical methods to 
determine whether variation in the SLC6A4 gene was associated with a statistically significant 
increased risk of developing OCD. While they did find some evidence of genetic association 
between the SLC6A4 gene and a propensity to develop OCD, their results were not statistically 
significant. However, when the authors stratified their sample by sex, they did find significant 
results for genetic association between a particular variant of the SLC6A4 gene and OCD in 
females. These results suggest that a genetic predisposition for developing OCD may be gender 
specific. 
 In their article, Pauls & Alsobrook (1999) suggested that genetic association studies were 
the final piece necessary to complete the etiologic puzzle of OCD. Since their article came out, 
several candidate gene studies have been published, yet no conclusions have been reached. 
Shugart and colleagues (2006) found evidence of linkage on several chromosomes but produced 
no statistically significant results due to the large scope of their study and the lack of statistical 
power in their results. Wang and colleagues (2009) targeted a single candidate gene and found 
statistically significant results. Voyiaziakis and colleagues (2011) conducted a similarly targeted 
genetic association study on the gene which codes for 5-HTT. They did not find statistically 
significant results overall, but did when the results were stratified by gender. Taken together 
these three studies suggest that future research must take a more targeted approach in searching 
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for OCD candidate genes, and that genetic association may be affected by other factors such as 
gender. 
Genetic Summary 
 The studies reviewed in this section provide evidence for a genetic predisposition to 
develop OCD in addition to linking the genes implicated in the etiology of OCD with the 
neurochemical dysfunction they are responsible for. Early studies investigated the inheritance of 
OCD by looking at cases where the disorder ran in families and twins. Another relevant line of 
research investigated white matter abnormalities in the brains of patients with OCD and searched 
for the genes responsible for these abnormalities. Finally, recent studies have taken advantage of 
new developments in genotyping technology to narrow down the search for potential candidate 
genes for OCD to a select few. These recent studies, which scanned the genome for specific 
genetic loci implicated in the etiology of OCD, provide hope for future research that the exact 
genes responsible for the disorder will be located and could hopefully be corrected for. 
Genetic Critique 
 The studies reviewed in this section present evidence that genetics has come a long way 
in the past couple decades. Early research concerning inheritance of OCD focused on family and 
twin studies which provided evidence through statistical analysis that OCD was very likely 
inheritable. While these studies were useful, they could only move the field further to a certain 
extent. By nature of their design, they lacked the ability to definitively pinpoint the genes 
responsible for this inheritance and thus were studies describing a problem with no solution as to 
how to fix it. 
 The early studies reviewed concerning white matter abnormalities were able to detect 
differences in white matter in the brains of OCD patients compared with healthy controls. Later 
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studies were able to determine a more exact nature and direction of these differences. More 
recent studies concerning white matter examined the gene responsible for regulating white matter 
(OLIG2) and found that OCD patients were predisposed to be polymorphic for the OLIG2 gene. 
The final and most recent white matter study reviewed conducted genotyping and MRI scans in 
order to determine that OCD patients not only were polymorphic for the OLIG2 gene but that 
they also exhibited the reduced white matter volume. Each successive study cited in this section 
built on the research of the last and improved it in a qualitative way. As MRI technology 
improved, researchers were able to more specifically describe the nature and direction of the 
white matter abnormalities. Innovation in genetic linkage allowed researchers to locate the gene 
responsible for regulating white matter, suggesting a possible candidate gene in the etiology of 
OCD. As technology improves even more, new studies will surely crop up elucidating the role 
these white matter abnormalities play in patients with OCD. 
 Recent genetic association studies reviewed have attempted to find the specific genetic 
loci responsible for the development of OCD. Shugart and colleagues (2006) conducted the first 
genomewide scan for linkage but because of the broad scope and low statistical power of their 
study, they failed to find any significant evidence of linkage. Wang and colleagues (2009) 
conducted a study targeting the COMT gene and did find statistically significant results linking 
this gene to OCD. Voyiaziakis and colleagues (2011) used the same sample as Shugart and 
colleagues (2006) to conduct a study targeting the SLC6A4 gene which codes for 5-HTT. They 
did not find statistically significant results overall but did find significant evidence of genetic 
linkage when the results were stratified by gender. These three studies represent the first attempts 
to pinpoint the gene or genes responsible for the etiology of OCD. While these studies were too 
broad to provide hard evidence of linkage, they identify several genetic loci which warrant 
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further investigation in the search for candidate genes for OCD. Future genetic association 
studies need to take a more targeted approach, taking into considerations the pitfalls of the 
current research such as small sample sizes and limited statistical analyses. While they did not 
find the definitive answers that Pauls and Alsobrook (1999) anticipated from genetic association 
studies, they do suggest that future research in genetics will be able to discern the gene or genes 
implicated in the development of the disorder.  
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Chapter Four 
The Convergence of Genetic and Neurochemical Underpinnings of OCD 
5-HTT Gene and Polymorphisms 
Much of the research I have reviewed so far has investigated the etiology of OCD from 
either a genetic or a neurochemical standpoint. Several recent studies have explored both of these 
routes simultaneously by examining the relationship between serotonergic candidate genes and 
5-HT dysfunction in the etiology of OCD (Denys et al., 2006; Lin, 2007; Grados et al., 2007; da 
Rocha et al., 2008; Liu et al., 2010). Denys and colleagues (2006) conducted a study to genotype 
a group of OCD patients and healthy controls to look for polymorphisms in the chromosome 
promoter regions which code for 5-HTT, 5-HT1B, and 5-HT2A. The authors chose these three 
promoter regions due to the demonstrated influence of the serotonergic system on the 
development of OCD. The authors did not find the strong correlations they expected; however, 
they did find an association between a higher frequency of the S-allele, associated with low 
expression of 5-HTT, in the 5-HTT promoter region in female OCD patients compared to female 
controls. They also found evidence that a variation on the 5-HT2A promoter region was 
associated with a positive family history of early onset OCD. These results, particularly the 5-
HTT genotype result, further support the notion put forth by Voyiaziakis and colleagues (2011) 
that OCD may be genetically heritable, particularly among females. In addition it appears that 
there is more evidence that early onset OCD has a genetic component than later onset OCD. 
Lin (2007) conducted a meta-analysis investigating the relationship between the 5-HTT 
gene polymorphism (5-HTTLPR) and OCD. He reviewed thirteen studies researching the 
association between genotypic frequencies and OCD. In his meta-analysis, Lin found that the SS 
genotype was associated with OCD but the LS genotype had an inverse association with OCD 
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suggesting a genetic protective effect. This makes sense in light of the finding that the S allele is 
associated with lower expression of 5-HTT whereas the L allele is associated with higher 
expression of 5-HTT. Overall, Lin found a significant correlation between the 5-HTTLPR and 
the OCD phenotype; however, specific variants of the 5-HTTLPR need to be studied in order to 
determine the exact nature of this correlation. 
Grados and colleagues (2007) built on previous studies investigating the 5-HTTLPR as a 
potential candidate gene for OCD. The authors of this study used genotyping to determine the 
allelic frequency and genotype of a sample of OCD probands. They did not find the expected 
significant correlation between the SS genotype or the S allele frequency and OCD. They did 
find that the SS genotype was associated with anxiety and OCD to a small degree but not 
significantly. The authors of this study suggest that a far greater sample of OCD patients is 
required to have the statistical power necessary to determine whether 5-HTTLPR is correlated 
with OCD. 
Da Rocha and colleagues (2008) suggest that the characteristic decision making 
impairment in patients with OCD could be explained through 5-HTTLPR’s dysfunctional effect 
on serotonin reuptake in the OFC, frontal lobe region associated with executive function. In 
order to answer this question, the authors administered a group of OCD patients a series of 
cognitive decision making tasks, the most prominent being the Iowa gambling task (IGT). They 
genotyped each patient using polymerase chain reaction to magnify the 5-HTT promoter region. 
The authors found a significant association between 5-HTTLPR and decision making processes 
such that individuals in the higher expression group had fewer symptoms of anxiety and 
performed significantly better than the low expressing group on the IGT. In choosing the 
cognitive tasks as a measure of dysfunction, the authors hope to inspire the use of phenotypic 
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variables which are more concrete as opposed to clinical definitions of a disorder. The findings 
of this study combine the findings that the OFC is a brain region prominently implicated in OCD 
and that 5-HTTLPR is a genetic polymorphism commonly implicated in OCD. The authors took 
this connection one step further by examining the relationship that 5-HTTLPR had on the 
cognitive processes mediated by the OFC, leading to a potential new cognitive way of measuring 
OCD. 
Liu and colleagues (2010) authored an article currently in press which examines the 
association of several potential candidate genes, including 5-HT2A gene and the COMT gene, to 
OCD in the genetically homogenous Chinese population. The genotyped a sample of 103 parent 
child trios diagnosed with OCD and found a significant association between late-onset OCD and 
the 5-HT2A gene polymorphism as well as a significant association between early-onset OCD and 
the 5-HT1B gene polymorphism. The most significant finding of the study was linkage 
disequilibrium with OCD in the 5-HT2A polymorphism. This finding suggests that the presence 
of the 5-HT2A polymorphism is significantly associated with late onset OCD.  
All of these recent studies suggest a connection between genetics and serotonergic 
dysfunction as the key to understanding the development of OCD. These studies built on 
previous research investigating heritability of OCD as well as studies examining serotonergic 
dysfunction as a potential cause of the disorder. The logical next step in research was to look into 
specific serotonergic candidate genes for OCD. Denys and colleagues’ (2006) study examined 
three candidate genes, 5-HTT, 5-HT1B, and 5-HT2A, all regions which previous research had 
implicated in the pathology of the disorder. These authors found associations between low 
expression of 5-HTT as well as 5-HT2A and OCD. The results of da Rocha and colleagues (2008) 
and Lin (2007) support the idea that the 5-HTTLPR is associated with OCD and the results of 
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Liu and colleagues (2010) support the notion that the 5-HT2A is associated with OCD. I find it 
interesting that the Denys and colleagues (2006) finding that the 5-HTT polymorphism is 
associated with OCD in females is further supported by Voyiaziakis and colleagues’ (2010) 
finding. In addition, the results of two of these studies conflict in that Denys and colleagues 
(2006) found that the 5-HT2A polymorphism was associated with early onset OCD whereas Liu 
and colleagues (2010) found that the 5-HT2A polymorphism was associated with late onset OCD. 
I do not think that these conflicting findings indicate that both are on the wrong track; instead I 
propose that the fact that these authors are finding associations between these candidate genes 
and OCD indicate that some relationship does exist and further research must be conducted to 
elucidate the nature of this relationship. 
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Chapter Five 
Integrated Summary and Critique 
In writing this review, my goal was to address the question of what the neurochemical 
and genetic underpinnings of OCD are. In order to answer this question I reviewed literature on 
the neurochemicals commonly implicated in OCD as well as literature on the genetic 
underpinnings of the disorder. In searching for these topics, I came across literature which 
examined both of these topics simultaneously by investigating the particular genetic loci which 
may code for the neurochemical dysfunction implicated in OCD. 
The bulk of the neurochemical research on OCD suggests that dysfunction in the 
serotonergic system is to blame for the development of the disorder. Some studies suggest a role 
for dopamine in the etiology of OCD (Kim et al., 2007; Olver et al., 2009). However, these 
studies indicate that the dysfunction in dopamine present in the striatum of patients with OCD is 
modulated by the amount of serotonin present, suggesting that the source of this neurochemical 
dysfunction lies in the serotonergic system. 
As is the case for most psychiatric medication, SSRIs were discovered to effectively 
reduce OCD symptoms before researchers had determined what caused the disorder in the first 
place or why SSRIs worked. Research into the pharmacological action of SSRIs indicated that 
they exerted their anti-OCD effects by increasing the amount of serotonin in the synapse leading 
researchers to investigate serotonergic dysfunction as a potential underpinning of OCD. 
However, SSRIs essentially bomb the brain with serotonin which means that there are many 
different mechanisms through which an increase in serotonin leads to a reduction in OCD 
symptoms. El Mansari & Blier (2006) report that in order to increase the amount of serotonin in 
the synapse, SSRIs actually desensitize the 5-HT1A receptor but not the 5-HT2A or 5-HT2C 
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receptors indicating that the anti-OCD effects of SSRIs could be a result of activation of the 
postsynaptic 5-HT2 receptors, receptors which are also implicated in the effects of hallucinogenic 
drugs such as LSD and psilocybin. 
Further evidence of serotonin’s role in the etiology of OCD comes from studies 
investigating the effects of 5-HT2 agonist hallucinogenic drugs on OCD. Zghoul and Blier (2003) 
found that LSD had an enhancing effect on OFC neurons’ responsiveness to serotonin in rodents. 
This finding links the research of Rauch and colleagues (1994) who name the OFC as part of the 
OCD worry circuit with previous SSRI research implicating a dysfunction of serotonin as a 
potential underpinning of OCD. LSD reduces OCD symptoms through enhancing OFC neurons’ 
responsiveness to serotonin. The drug’s role as a 5-HT2 agonist suggests that this receptor is 
implicated in the development of the disorder. Moreno and colleagues (2006) found that the 
administration of psilocybin had a statistically significant reduction in patient’s OCD symptoms 
and that patients tolerated the procedure well. Taken together, the results of these studies suggest 
that the anti-OCD effects exerted by these hallucinogenic drugs implicate the 5-HT2 receptors 
specifically and that novel OCD medication might target these receptors to produce more 
beneficial effects with a faster onset. 
There is a substantial body of evidence provided by recent research which implicates 5-
HTT dysfunction in the etiology of OCD. Technological advances in MRI technology have 
allowed researchers in several studies to investigate the nature and direction of 5-HTT 
dysfunction as measured by SPECT (Stengler-Wenzke et al., 2004; Hasselbalch et al., 2007; 
Zitterl et al., 2007; Matsumoto et al., 2010). All of these studies found that 5-HTT dysfunction in 
various brain regions were associated with OCD. The findings were not completely consistent 
between studies. However, the fact that all of these studies found significance in some brain 
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region indicates a potential connection between 5-HTT dysfunction and OCD. Future research 
must be conducted to determine the exact nature and directionality of this relationship. 
Research on the heritability of OCD began with twin and family studies, most notably 
Clifford and colleagues (1984). While Clifford and colleagues (1984) were the first to identify 
this familial trend, their study paved the way for research investigating environmental factors 
(Van Grootheest et al., 2007; Wilcox et al., 2008). Recent research on the inheritance of OCD 
has also suggested that certain clusters of symptoms may be more heritable than the disorder 
itself (Hasler et al., 2007). Finally, Katerberg and colleagues (2010) found that OCD in general, 
as well as certain symptom dimensions of the disorder are heritable, and that the genes 
responsible for the heredity of the disorder as a whole are different from those genes responsible 
for certain clusters of obsessive-compulsive symptoms. Taken together, these studies provide a 
strong case that OCD runs in families and that the exact nature of this inheritance may be more 
complex than originally conceived. Further research on heredity is necessary however, as Pauls 
& Alsobrook (1999) pointed out, this research will most likely come in the form of genetic 
association studies to search for the specific genes responsible for the disorder. 
Abnormalities in the white matter (myelinated axons) of the brains of patients with OCD 
have been discovered by several researchers. Garber and colleagues (1989) were the first to 
identify differences in the white matter in the MRI scans of OCD patients compared with healthy 
controls.  Jenike and colleagues (1996) furthered research on this topic by identifying the 
postero-inferior periocallosal, retrocallosal, and cerebellar regions of the brains of OCD patients 
as being deficient in white matter compared with brains of healthy controls. Szeszko and 
colleagues (2005) and Nakamae and colleagues (2008) used an MRI technique called DTIto 
better measure the nature and direction of these abnormalities and found poor diffusion in brain 
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regions associated with OCD. Stewart and colleagues (2007) investigated the OLIG2 gene, 
which codes for oligodendrocyte which is responsible for producing white matter. They found 
the suspected polymorphism in the OLIG2 gene in a sample of patients with OCD, suggesting 
that this gene may be responsible for the development of these white matter abnormalities which 
may lead to the development of the disorder. Finally, Atmaca and colleagues (2010) conducted a 
study which consisted of genotyping a sample of OCD patients to determine whether they had 
the OLIG2 polymorphism and using MRI techniques to identify the white matter abnormalities 
themselves. Taken together these studies provide a body of evidence suggesting that patients 
with OCD exhibit characteristic deficiencies in white matter and that the gene which codes for 
the protein which is responsible for these deficiencies may prove to be a potential candidate gene 
for the disorder. 
New technology has allowed researchers to search with greater precision for specific 
genes which may be implicated in OCD. Shugart and colleagues’ (2006) study consists of a 
genomewide search for specific genes which are linked to OCD. While they did find some 
evidence of genetic linkage on several chromosomes their results were not significant, most 
likely due to the lack of statistical power. The authors of this study nevertheless paved the way 
for researchers to further hone in on candidate genes for OCD. Wang and colleagues (2009) 
investigated the COMT to determine whether a polymorphism in this gene could be linked to the 
development of OCD. These authors did find a significant association between COMT and OCD. 
This finding is especially salient considering that COMT is responsible for regulating the amount 
of dopamine in the prefrontal cortex, a region associated with OCD. Voyiaziakis and colleagues 
(2011) took up where Shugart and colleagues’ (2006) study left off by targeting one specific 
candidate gene, SLC6A4, the gene which codes for 5-HTT. While they did not find a significant 
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association in the overall sample, they did find a significant association when the results were 
stratified by gender. Female OCD patients were significantly more likely to have the 
polymorphic variant of the SLC6A4 gene than were healthy controls. This finding provides 
evidence for a gender division in the heritability of the disorder. The results of these three studies 
suggest that the search for potential candidate genes in the development of OCD will lead to 
answers in the etiology of the disorder. While these three studies do not draw definitive 
conclusions, they do provide hope in the search for an understanding of the genetics of OCD. 
Research into the etiology of OCD primarily concerns itself with genetic or 
neurochemical underpinnings. However, perhaps the most promising studies into the 
development of the disorder investigate the point where these two areas intersect. Recent studies 
examining the convergence of neurochemical and genetic underpinnings in the form of the 
polymorphic serotonergic candidate genes provide a clear picture of the future of this research. 
Denys and colleagues (2006) studied the promoter regions for 5-HTT, 5-HT1B, and 5-HT2A to 
search for an association between abnormal expression of these genes and OCD. These authors 
found an association between low expression of the 5-HTT and 5-HT2A genes and OCD.  These 
results are further supported by the findings of Lin (2007) and da Rocha (2008) who found an 
association between the 5-HTTLPR and OCD. In addition, Liu and colleagues’ (2010) results 
support the Denys and colleagues (2006) finding that the polymorphic 5-HT2A promoter region is 
associated with OCD. Grados and colleagues (2007) were the only one of these studies which did 
not find a significant association between serotonergic candidate genes and OCD. Nevertheless, 
they did find a slight correlation between the polymorphic 5-HTT promoter region and anxiety 
and OCD generally. Taken together, the results of these studies make a strong case suggesting 
polymorphisms in serotonergic candidate genes could potentially cause OCD. Future research 
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focusing on this convergence of genetics and neurochemicals which are responsible for OCD is 
necessary to fully elucidate the mechanisms behind this dysfunction. However, these studies 
provide promising results which aid our understanding of potential underpinnings of OCD. 
Of all the studies I have reviewed in this project, the serotonergic candidate gene studies 
offer the strongest evidence that this line of research may ultimately lead to answers regarding 
the etiology of OCD. These studies represent a convergence of neuroscience and genetics which 
seek to identify particular regions along chromosomes which are polymorphic in patients with 
OCD. Patients who exhibit these polymorphic regions have an abnormally low expression of 5-
HTT and 5-HT2A. This low expression of serotonin is associated with OCD symptoms as 
evidenced by the beneficial effects of 5-HT2 agonist hallucinogenic drugs on patients with OCD. 
Judging by the limitations in the findings of several studies, the genetic predisposition for 5-HT 
polymorphic genes seems to be affected by factors such as gender: Denys and colleagues (2006) 
and Voyiaziakis and colleagues (2011) found that a 5-HTT polymorphism thought to be 
responsible for the development of OCD was significant only in female patients. Age of onset 
represents another factor affecting genetic predisposition for polymorphic genes: Denys and 
colleagues (2006) and Liu and colleagues’ (2010) findings conflict about whether a 5-HT2A 
polymorphism was associated with either early or late onset OCD. While the exact manner in 
which these polymorphisms are linked with the etiology of OCD is uncertain, there is a 
substantial body of evidence that suggests that these polymorphic regions may turn out to be the 
genetic coding for the etiology of OCD. 
These studies represent the closest that the fields of neuroscience and genetics have come 
to explaining the development of OCD. There are no definitive answers yet as to why this 
disorder develops. The results of these studies collectively suggest that OCD is a genetically 
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inheritable disorder and that the neurochemical dysfunction which is inherited is related to the 
serotonin system, more specifically the serotonin transporter and the 5-HT2 receptors. While 
most of the studies I have reviewed focus on finding a biological basis for the disorder, some of 
these studies attempt to answer the question of whether more effective medication might be 
developed to help alleviate symptoms. El mansari and Blier (2006) investigated the 
pharmacological action of SSRIs, the current medication of choice for OCD, and found results 
which suggest that SSRIs may actually exert their effects by increased serotonin binding at the 5-
HT2A receptor, the same receptor activated by hallucinogenic drugs such as LSD and psilocybin 
which are known to rapidly reduce OCD symptoms. Denys and colleagues (2006) and Liu and 
colleagues’ (2010) finding that a polymorphic variant of the gene which codes for the 5-HT2A 
receptor was associated with OCD further supports this notion that the 5-HT2A receptor is 
implicated in the behavioral symptoms of the disorder. Together these studies suggest that novel 
medication, which specifically targets the 5-HT2A receptor, may prove to be the future of faster 
acting, more effective treatment for OCD. 
Limitations 
In attempting to answer the question what are the neurochemical and genetic 
underpinnings of OCD, I chose to conduct a literature review. While I was able to draw some 
conclusions about the neurochemicals and genes potential implicated in the development of 
OCD, my review lacked the weight of an empirical study and the statistical power of a meta-
analysis. I chose to describe the state of current research on OCD in order to gain a better 
understanding of this topic myself, and to hopefully draw some conclusions about where the 
future of this line of research lies. By researching both the serotonergic imbalance associated 
with OCD, and the candidate genes currently thought to code for the disorder, I was able to 
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articulate not only which genes are implicated in OCD, but also why they lead to the 
development of the disorder through neurochemical changes. While I may not have come up 
with any definitive answers to this question, I have identified the state of the research on this 
topic and predicted where the future of this investigation may lead. 
Future Research 
Future research into the biology of OCD is necessary in order to find solutions to issues 
brought up in the studies in this review. The future of neurochemical research into the etiology of 
OCD needs to be able to identify the exact serotonergic imbalance which SSRIs correct. Because 
of the beneficial effects of 5-HT2A hallucinogens on OCD patient’s symptoms, I suggest that the 
5-HT2 receptor system is that mechanism. I think that these receptors need to be investigated 
further in order to understand why hallucinogens exert this therapeutic effect. Ideally, the 
beneficial effects of hallucinogens could be harnessed for their therapeutic value without the 
added cognitive confusion caused by these drugs. Additionally, the serotonergic imbalance 
seems to be caused at least in part by a dysfunction of the serotonin transporter. Future research 
needs to identify ways in which this imbalance can be corrected in a more efficient manner than 
OCD medication currently on the market. Ultimately, future research into this topic should yield 
results in the form of newer, more effective medication for patients with OCD. 
Most of the limitations in the reviewed genetic studies are a result of researchers casting 
too small or too large of a net. Some candidate gene studies tested for only one specific 
polymorphism whereas other studies conducted a genomewide search for abnormalities, and 
lacked the power to say definitively whether any one specific polymorphic region was 
significantly associated with OCD. While these broad searches for genetic linkage are useful for 
identifying several regions which exhibit some association with obsessive behavior, future 
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research must take the results of these genomewide scans and conduct more focused studies with 
greater statistical power in order to determine whether the polymorphic regions identified by the 
broader studies are indeed significantly associated with the etiology of OCD. Once future 
research has identified the gene or genes responsible for the development of the disorder, 
medical professionals will be able to predict with great accuracy whether an individual is at risk 
for OCD. This knowledge could dramatically shift the way society views the disorder, from 
stigmatization to acceptance as a medical illness with a biological basis. 
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